Growth Metrics

Armata Pharmaceuticals (ARMP) Gains from Sales and Divestitures (2021 - 2026)

Quarterly results put Gains from Sales and Divestitures at $17500.0 for Q1 2026, changed 0.0% from a year ago — trailing twelve months through Mar 2026 was $17500.0 (changed 0.0% YoY), and the annual figure for FY2025 was $67500.0, up 35.0%.

Armata Pharmaceuticals has reported Gains from Sales and Divestitures over the past 6 years, most recently at $17500.0 for Q1 2026.

  • Gains from Sales and Divestitures reached $17500.0 in Q1 2026 per ARMP's latest filing, down from $67500.0 in the prior quarter.
  • Across five years, Gains from Sales and Divestitures topped out at $102325.0 in Q4 2023 and bottomed at $17500.0 in Q1 2025.
  • Median Gains from Sales and Divestitures over the past 5 years was $50000.0 (2024), compared with a mean of $43967.4.
  • The largest annual shift saw Gains from Sales and Divestitures crashed 85.7% in 2022 before it skyrocketed 326.66% in 2023.
  • Over 5 years, Gains from Sales and Divestitures stood at $23983.0 in 2022, then surged by 326.66% to $102325.0 in 2023, then plummeted by 51.14% to $50000.0 in 2024, then surged by 35.0% to $67500.0 in 2025, then crashed by 74.07% to $17500.0 in 2026.
  • Business Quant data shows Gains from Sales and Divestitures for ARMP at $17500.0 in Q1 2026, $67500.0 in Q4 2025, and $67500.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn -
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn -
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn -
5 Akari Therapeutics 605.66 Bn 605.66 Bn -
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn
8 Evaxion A 65.12 Bn 65.10 Bn -
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn
10 Armata Pharmaceuticals 301.92 Mn 297.17 Mn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 17,500.00
Mar 31, 2026 17,500.00
Dec 31, 2025 67,500.00
Dec 31, 2025 67,500.00
Sep 30, 2025 67,500.00
Sep 30, 2025 67,500.00
Jun 30, 2025 17,500.00
Jun 30, 2025 17,500.00
Mar 31, 2025 17,500.00
Mar 31, 2025 17,500.00
Dec 31, 2024 50,000.00
Dec 31, 2024 50,000.00
Sep 30, 2024 50,000.00
Sep 30, 2024 50,000.00
Dec 31, 2023 102,325.00
Dec 31, 2023 102,325.00
Sep 30, 2023 54,901.00
Sep 30, 2023 54,901.00
Jun 30, 2023 54,901.00
Jun 30, 2023 54,901.00
Dec 31, 2022 23,983.00
Dec 31, 2022 23,983.00
Sep 30, 2022 23,983.00
Sep 30, 2022 23,983.00
Jun 30, 2022 23,983.00
Jun 30, 2022 23,983.00
Dec 31, 2021 167,691.00
Dec 31, 2021 167,691.00
Sep 30, 2021 167,691.00
Sep 30, 2021 167,691.00
Jun 30, 2021 167,691.00
Jun 30, 2021 167,691.00